Search

everythinglearnresearchcommunity

for

Search:↓

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Lowering homocyst(e)ine levels can reverse skin and hair lightening by restoring enzyme activity needed for pigmentation.

PXX is an effective and affordable photocatalyst for creating new chemical bonds in organic synthesis.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Low PON1 levels may indicate and predict the severity of hair loss.

Higher CO2 levels help a cyanobacterium grow better by boosting photosynthesis and carbon uptake.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

"Coco de mono" seeds cause temporary hair loss due to selenocystathionine.

Fermentation of Finasteride with Ocimum sanctum L. creates new metabolite that inhibits tyrosinase.

5% topical minoxidil improves hair density and quality in monilethrix patients.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

α-MSH and cyclic AMP boost melanin production, while cyclic GMP and melatonin reduce it.

Liver enzyme helps minoxidil work better for blood vessel relaxation.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Minoxidil caused hair regrowth, but cyproterone acetate did not maintain it.

Finasteride is mainly broken down by the enzyme CYP3A4, affecting its levels in the body.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Tunable structured metal oxides show promise for various medical treatments due to their versatility and cost-effectiveness.

A new method accurately measures clobetasol propionate in hair and skin.

CoCr2O4 catalysts effectively and sustainably produce diaminopyrimidine oxides with high yield.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.